Last reviewed · How we verify
NCT06324318: (P2W)
Parenting in 2 Worlds Multisite Trial
Phase 2 trial testing Parenting in 2 Worlds (P2W) in Parenting in 1,440 participants. Currently enrolling.
1 May 2027
Quick facts
| Lead sponsor | Arizona State University |
|---|---|
| Phase | Phase 2 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 1,440 |
| Start date | 14 September 2023 |
| Primary completion | 1 May 2027 |
| Estimated completion | 1 June 2028 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Parenting in 2 Worlds (P2W)
- Healthy Families in 2 Worlds (HF2W)
Conditions studied
- Parenting — all drugs for Parenting →
- Mental Health Wellness 1 — all drugs for Mental Health Wellness 1 →
- Substance Use — all drugs for Substance Use →
- Risky Health Behavior — all drugs for Risky Health Behavior →
Sponsor
Arizona State University
Who can join
12 and older, any sex, with Parenting or Mental Health Wellness 1. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research study will test the effectiveness of a culturally grounded parenting intervention called Parenting in 2 Worlds (P2W). This intervention is designed for American Indian / Alaska Native (AI) parents/guardians of adolescents who reside in urban areas. This will be a multi-regional effectiveness trial across four regions: Northeast (Buffalo/Niagara), Midwest (St. Paul/Minneapolis), Mountain (Denver), and Southwest (Phoenix). There are four specific aims. First, this study will test the effectiveness of Parenting in Two Worlds (P2W) as compared to an informational family health intervention, Healthy Families in 2 Worlds (HF2W), in improving parenting and family functioning. Second, this study will test if the relative effectiveness of P2W, compared to HF2W, varies by parent's/guardian's level of socioeconomic vulnerability, experiences of historical loss, or AI cultural identity. Third, this study will examine if P2W can reduce adolescent (ages 12 - 17) risky health behaviors including substance use, depressive symptoms, suicidality, and risky sexual behaviors. Fourth, this study will examine whether positive changes in parenting and family functioning that result from P2W lead to positive changes in adolescent's health behaviors.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06324318
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parenting
Currently open trials in the same condition.
- NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
- NCT06823518 — Thrive Initiative Parent-Education Programming Study · NA · recruiting
- NCT07494786 — Palestinian ParentText for Crisis · NA · recruiting
- NCT06569303 — Filipino Family Health Initiative 1.0 · NA · recruiting
- NCT07008651 — Digital Parenting Education: Impact on Mothers' Social Media Use and Children's Tech Attitudes · NA · recruiting
Other Arizona State University trials
Trials by the same sponsor.
- NCT07519408 — Acute Kidney Injury and Ultra-endurance Running · NA · not yet recruiting
- NCT05784467 — Methamphetamine, PrEP, and Intersectional Stigma Study · NA · not yet recruiting
- NCT07375043 — Drumming Groups for Parents of Autistic Children · NA · not yet recruiting
- NCT07297901 — App-based Breathing Program for Migraine Relief · NA · enrolling by invitation
- NCT06721793 — The Impact of a Caffeinated Sports Drink on Performance · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06324318 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arizona State University
- Last refreshed: 18 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06324318.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing